ÂÜÀòÂÒÂ×

Pierre Deludet is an experienced investor currently working at Sango Capital since 2023 and serving as a board member at Hoveraid UK since 2019. Deludet has held significant roles in various companies, including a position as M&A/Investments at Bertelsmann SE & Co. KGaA in 2022, and as Director at Neofelis from 2020 to 2022, providing senior advisory services to corporate management teams on client engagements including PZ Cussons plc, Bboxx, and Memo Therapeutics. Additional experience includes investment roles at Tiger Hill Global and Moelis & Company, where Deludet served as Vice President from 2010 to 2018. Deludet's early career included roles as General Secretary at UCLU and in European M&A at Baird. Academically, Deludet holds a BSc in Theoretical Physics from UCL, completed in 2011.